Speciality Medicines Ltd Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 0 | NSE: | Trading |

BSE Share Price
Not Listed

Speciality Medicines Ltd Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 0 | NSE: | Trading |

DeciZen - make an informed investing decision on Speciality Medicines

Based on:

DeciZen not available for IPO

10 Year X-Ray of Speciality Medicines:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 69.8%52.4%37.7%34.5%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 40.423.227.558.30
Sales YoY Gr.--42.5%18.4%111.7%-
Adj EPS 4.74.45.613.20
YoY Gr.--6%25.6%136.9%-
BVPS (₹) 6.115.429.447.30
Adj Net
Profit
1.51.72.88.5NAN
Cash Flow from Ops. 0.8-4.2-4.8-5.8-
Debt/CF from Ops. 1.5-0.9-0.6-0.9-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANA13%111.7%
Adj EPS NANA40.9%136.9%
BVPSNANA97.6%60.5%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
76.643.327.137.20
Op. Profit
Mgn %
5.615.419.215.7NAN
Net Profit
Mgn %
3.77.310.314.5NAN
Debt to
Equity
0.60.60.20.2-
Working Cap
Days
01152111810
Cash Conv.
Cycle
0801601320

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Speciality Medicines Ltd.

Standalone Consolidated
TTM EPS (₹) - -
TTM Sales (₹ Cr.) - -
BVPS (₹.) - -
Reserves (₹ Cr.) - -
P/BV - -
PE - -
From the Market
52 Week Low / High (₹) - / -
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) -
Equity (₹ Cr.) -
Face Value (₹) -
Industry PE -

Management X-Ray of Speciality Medicines:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Speciality Medicines - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Speciality Medicines

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Sales40.4423.2427.5258.27
Operating Expenses 38.1619.6622.2549.14
Manufacturing Costs0.150.150.090.14
Material Costs35.0416.2818.2042.17
Employee Cost 0.820.750.880.89
Other Costs 2.162.483.085.94
Operating Profit 2.283.585.279.13
Operating Profit Margin (%) 5.6%15.4%19.2%15.7%
Other Income 00.020.130.27
Interest 0.030.350.620.51
Depreciation 0.110.300.230.20
Exceptional Items 0000
Profit Before Tax 2.142.954.568.69
Tax 0.661.261.620.08
Profit After Tax 1.481.692.938.61
PAT Margin (%) 3.7%7.3%10.7%14.8%
Adjusted EPS (₹)4.74.45.713.4
Dividend Payout Ratio (%)0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 1.935.8715.0630.42
Share Capital 0.213.825.126.44
Reserves 1.722.059.9523.98
Minority Interest0000
Debt1.182.862.573.80
Long Term Debt01.170.852.61
Short Term Debt1.181.691.731.19
Trade Payables1.181.802.410.97
Others Liabilities 1.482.712.584.79
Total Liabilities 5.7813.2422.6339.98

Fixed Assets

Gross Block2.022.102.112.80
Accumulated Depreciation0.110.410.640.84
Net Fixed Assets 1.911.691.471.97
CWIP 0.070.070.090
Investments 0.210.100.100.10
Inventories0.484.608.0317.38
Trade Receivables2.595.5110.719.58
Cash Equivalents 0.080.260.250.85
Others Assets 0.431.011.9810.11
Total Assets 5.7813.2422.6339.98

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 0.81-4.21-4.80-5.79
PBT 2.142.954.568.69
Adjustment 0.150.640.880.74
Changes in Working Capital -1.48-7.21-8.95-15.22
Tax Paid 0-0.60-1.290
Cash Flow From Investing Activity -2.330.03-0.03-2.07
Capex -2.09-0.08-0.03-0.61
Net Investments -0.210.110-0
Others -0.03-00-1.46
Cash Flow From Financing Activity 1.604.374.818.46
Net Proceeds from Shares 0.452.256.176.74
Net Proceeds from Borrowing 01.17-1.062.47
Interest Paid -0.03-0.34-0.60-0.47
Dividend Paid 0000
Others 1.181.300.31-0.28
Net Cash Flow 0.080.18-0.010.60

Finance Ratio

PARTICULARSMar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)76.5643.328.0337.85
ROCE (%)69.7552.4137.7234.47
Asset Turnover Ratio72.441.531.86
PAT to CFO Conversion(x)0.55-2.49-1.64-0.67
Working Capital Days
Receivable Days236410864
Inventory Days4408480
Payable Days12334215

Speciality Medicines Ltd Stock News

Speciality Medicines Ltd FAQs

The current trading price of Speciality Medicines on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Speciality Medicines stood at ₹0.00.
The latest P/E ratio of Speciality Medicines as of 31-Dec-1969 is 0.00.
The latest P/B ratio of Speciality Medicines as of 31-Dec-1969 is 0.00.
The 52-week high of Speciality Medicines is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Speciality Medicines is ₹0.00 ( Cr.) .

About Speciality Medicines Ltd

No data to display
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×